By uniting expertise and resources, Georgia’s leading institutions are creating practical solutions to improve health outcomes across the state.
Inspired by NASA technology, Georgia Tech alumni launched Deleon—a startup using biochemical data to advance preventive health, backed by CREATE-X.
Georgia Tech’s Fall 2025 I2P Showcase will feature over 60 student prototypes tackling real-world challenges.
Two years into a $49.5 million cancer-mapping project, researchers are opening the door to new kinds of tests that could alert doctors to multiple kinds of cancer when they’re most treatable.
Born with a congenital limb disorder, Wallace wants to use his own experience to develop new prosthetics.
Georgia Tech and Vanderbilt researchers have built the first lung-on-a-chip with a working immune system, a breakthrough with the potential to reshape how we study disease, move beyond animal testing, and administer lifesaving therapies.
Nexus is Georgia Tech’s next-generation supercomputer, replacing the HIVE.
Schmidt Sciences announces next cohort of early-to mid- career scientists to each receive up to $2.5 million to pursue novel research
Record-breaking numbers from the Office of Commercialization drive meaningful inventions, IP, and industry partnerships.
Engineers use sodium bicarb to “self-pressurize” a pill able to deliver drugs that usually require injection directly to the small intestine.